J. Zhang and Q. M. Chen, Far upstream element binding protein 1: a commander of transcription, translation and beyond, Oncogene, vol.32, pp.2907-2916, 2013.

M. I. Avigan, B. Strober, and D. Levens, A far upstream element stimulates c-myc expression in undifferentiated leukemia cells, J Biol Chem, vol.265, pp.18538-18545, 1990.

R. Duncan, L. Bazar, and G. Michelotti, A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNAbinding motif, Genes Dev, vol.8, pp.465-480, 1994.

D. Levens, How the c-myc Promoter Works and Why It Sometimes Does Not, JNCI Monogr, pp.41-43, 2008.

J. Liu, H. Chung, and M. Vogt, JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress, EMBO J, vol.30, pp.846-858, 2011.

M. Malz, A. Weber, and S. Singer, Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells, Hepatology, vol.50, pp.1130-1139, 2009.

M. Malz, M. Bovet, and J. Samarin, Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma, Hepatology, vol.60, pp.1241-1250, 2014.

U. Rabenhorst, R. Beinoraviciute-kellner, and M. Brezniceanu, Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth, Hepatology, vol.50, pp.1121-1129, 2009.

P. Baumgarten, P. N. Harter, and M. Tönjes, Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity: FUBP1 expression in human gliomas, Neuropathol Appl Neurobiol, vol.40, pp.205-216, 2014.

J. Duan, X. Bao, and X. Ma, Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma, PLOS ONE, vol.12, 2017.

S. Hauck, K. Hiesinger, K. Hosseini, and S. , Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitors, Bioorg Med Chem, vol.24, pp.5717-5729, 2016.

D. W. Felsher and J. M. Bishop, Transient excess of MYC activity can elicit genomic instability and tumorigenesis, Proc Natl Acad Sci U S A, vol.96, pp.3940-3944, 1999.

J. Liu, L. He, and I. Collins, The FBP Interacting Repressor Targets TFIIH to Inhibit Activated Transcription. Mol Cell, vol.5, issue.00, pp.80428-80429, 2000.

J. Liu, F. Kouzine, and Z. Nie, The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression, EMBO J, vol.25, pp.2119-2130, 2006.

K. Matsushita, T. Tomonaga, and H. Shimada, An Essential Role of Alternative Splicing of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor in Carcinogenesis, Cancer Res, vol.66, pp.1409-1417, 2006.

G. V. Crichlow, H. Zhou, and H. Hsiao, Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition, EMBO J, vol.27, pp.277-289, 2008.

A. Weber, J. Liu, I. Collins, and D. Levens, TFIIH Operates through an Expanded Proximal Promoter To Fine-Tune c-myc Expression, Mol Cell Biol, vol.25, pp.147-61, 2005.

C. I. Rubin and G. F. Atweh, The role of stathmin in the regulation of the cell cycle, J Cell Biochem, vol.93, pp.242-250, 2004.

S. J. Mistry and G. F. Atweh, Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy, Mt Sinai J Med N Y, vol.69, pp.299-304, 2002.

B. Belletti, M. S. Nicoloso, and M. Schiappacassi, Stathmin activity influences sarcoma cell shape, motility, and metastatic potential, Mol Biol Cell, vol.19, pp.2003-2013, 2008.

R. Kuner, T. Muley, and M. Meister, Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes, Lung Cancer Amst Neth, vol.63, pp.32-38, 2009.

R. Krumlauf, Hox genes in vertebrate development, Cell, vol.78, pp.191-201, 1994.

H. J. Lawrence, G. Sauvageau, R. K. Humphries, and C. Largman, The role of HOX homeobox genes in normal and leukemic hematopoiesis, Stem Cells Dayt Ohio, vol.14, pp.281-291, 1996.

V. C. Broudy, Stem cell factor and hematopoiesis, Blood, vol.90, pp.1345-1364, 1997.

Y. Kitamura and S. Hirotab, Kit as a human oncogenic tyrosine kinase, Cell Mol Life Sci CMLS, vol.61, pp.2924-2931, 2004.

A. L. Gartel, M. S. Serfas, and A. L. Tyner, negative regulator of the cell cycle, Proc Soc Exp Biol Med Soc Exp Biol Med N Y N, vol.213, pp.138-149, 1996.

A. L. Gartel and A. L. Tyner, The role of the cyclin-dependent kinase inhibitor p21 in apoptosis, Mol Cancer Ther, vol.1, pp.639-649, 2002.

G. Soria, J. Speroni, and O. L. Podhajcer, differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation, J Cell Sci, vol.121, pp.3271-3282, 2008.

U. Dixit, Z. Liu, and A. K. Pandey, Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53, BMC Cancer, vol.14, 2014.

U. Dixit, A. K. Pandey, and Z. Liu, FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53, J Virol, vol.89, pp.7905-7921, 2015.

J. R. Frost, M. Mendez, and A. M. Soriano, Adenovirus 5 E1A-mediated suppression of p53 via FUBP1, J Virol, 2018.

G. Sully, J. Dean, and R. Wait, Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-elementbinding protein 1), Biochem J, vol.377, pp.629-639, 2004.

Z. Zhang, D. Harris, and V. N. Pandey, The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C Virus, J Virol, vol.82, pp.5761-5773, 2008.

D. Caput, B. Beutler, and K. Hartog, Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators, Proc Natl Acad Sci U S A, vol.83, pp.1670-1674, 1986.

T. Zhang, V. Kruys, G. Huez, and C. Gueydan, AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors, Biochem Soc Trans, vol.30, pp.952-958, 2002.

G. Roberto, C. Chinggyi, and T. Michele, The role of KSRP in mRNA decay and microRNA precursor maturation, Wiley Interdiscip Rev RNA, vol.1, pp.230-239, 2010.

A. G. Jacob, R. K. Singh, and F. Mohammad, The Splicing Factor FUBP1 Is Required for the Efficient Splicing of Oncogene MDM2 Pre-mRNA, J Biol Chem, vol.289, pp.17350-17364, 2014.

J. Miro, A. M. Laaref, and V. Rofidal, FUBP1: a new protagonist in splicing regulation of the DMD gene, Nucleic Acids Res, vol.43, pp.2378-2389, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01279092

W. Zheng, F. Shen, and R. Hu, Far Upstream Element-Binding Protein 1 Binds the 3' Untranslated Region of PKD2 and Suppresses Its Translation, J Am Soc Nephrol, 2016.

N. Irwin, V. Baekelandt, L. Goritchenko, and L. I. Benowitz, Identification of two proteins that bind to a pyrimidine-rich sequence in the 3'-untranslated region of GAP43 mRNA, Nucleic Acids Res, vol.25, pp.1281-1288, 1997.

M. E. Olanich, B. L. Moss, and D. Piwnica-worms, Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation, Oncogene, vol.30, pp.77-86, 2011.

J. K. Box, N. Paquet, and M. N. Adams, Nucleophosmin: from structure and function to disease development, BMC Mol Biol, vol.17, 2016.

B. Y. Williams, S. L. Hamilton, and H. K. Sarkar, The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain, FEBS Lett, vol.470, pp.207-210, 2000.

Y. Zheng and W. K. Miskimins, Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site, Int J Biochem Cell Biol, vol.43, pp.1641-1648, 2011.

P. Huang, J. Lin, and N. Locker, Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth, Nucleic Acids Res, vol.39, pp.9633-9648, 2011.

F. Tsai, C. Lin, and C. Lai, Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins, Food Chem, vol.128, pp.312-322, 2011.

C. Hung, Y. Kung, and M. Li, Additive Promotion of Viral Internal Ribosome Entry Site-Mediated Translation by Far Upstream Element-Binding Protein 1 and an Enterovirus 71-Induced Cleavage Product, PLoS Pathog, vol.12, 2016.

J. Lin, M. Li, and S. Shih, Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation, Nucleic Acids Res, vol.37, pp.47-59, 2009.

H. Min, C. W. Turck, J. M. Nikolic, and D. L. Black, A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer, Genes Dev, vol.11, pp.1023-1036, 1997.

E. Labourier, M. D. Adams, and D. C. Rio, Modulation of P-Element Pre-mRNA Splicing by a Direct Interaction between PSI and U1 snRNP 70K Protein, Mol Cell, vol.8, pp.311-313, 2001.

J. Rappsilber, U. Ryder, A. I. Lamond, and M. Mann, Large-Scale Proteomic Analysis of the Human Spliceosome, Genome Res, vol.12, pp.1231-1245, 2002.

,

Q. Pan, O. Shai, and L. J. Lee, Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing, Nat Genet, vol.40, pp.1413-1415, 2008.

H. Li, Z. Wang, and X. Zhou, Far upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repression, Proc Natl Acad Sci, vol.110, pp.2687-2695, 2013.

C. L. Will and R. Lührmann, Spliceosome Structure and Function, Cold Spring Harb Perspect Biol, vol.3, 2011.

J. Wang, P. G. Schultz, and K. A. Johnson, Mechanistic studies of a small-molecule modulator of SMN2 splicing, Proc Natl Acad Sci U S A, vol.115, pp.4604-4612, 2018.

D. A. Freedman, L. Wu, and A. J. Levine, Functions of the MDM2 oncoprotein, Cell Mol Life Sci CMLS, vol.55, pp.96-107, 1999.

A. Emery, The muscular dystrophies, Lancet Lond Engl, vol.359, pp.7815-7822, 2002.

F. Sutandy, S. Ebersberger, and L. Huang, In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors, Genome Res, vol.28, pp.699-713, 2018.

I. Hwang, D. Cao, and Y. Na, Far Upstream Element-Binding Protein 1 Regulates LSD1 Alternative Splicing to Promote Terminal Differentiation of Neural Progenitors, Stem Cell Rep, 2018.

Q. T. Ostrom, L. Bauchet, and F. G. Davis, The epidemiology of glioma in adults: a "state of the science, review. Neuro-Oncol, vol.16, pp.896-913, 2014.

,

V. Barbashina, P. Salazar, and E. C. Holland, Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene, Clin Cancer Res Off J Am Assoc Cancer Res, vol.11, pp.1119-1128, 2005.

F. Sahm, C. Koelsche, and J. Meyer, CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas, Acta Neuropathol (Berl), vol.123, pp.853-860, 2012.

A. Chan, J. Pang, and N. Chung, Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors, Mod Pathol Off J U S Can Acad Pathol Inc, vol.27, pp.332-342, 2014.

C. Network, D. J. Brat, and R. Verhaak, Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, N Engl J Med, vol.372, pp.2481-2498, 2015.

H. Suzuki, K. Aoki, and K. Chiba, Mutational landscape and clonal architecture in grade II and III gliomas, Nat Genet, vol.47, pp.458-468, 2015.

K. Aihara, A. Mukasa, and G. Nagae, Genetic and epigenetic stability of oligodendrogliomas at recurrence, Acta Neuropathol Commun, vol.5, 2017.

S. Kawate, T. Fukusato, and S. Ohwada, Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression, Oncology, vol.57, pp.157-163, 1999.

,

H. B. El-serag and K. L. Rudolph, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, vol.132, pp.2557-2576, 2007.

,

H. Murakami, N. D. Sanderson, and P. Nagy, Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis, Cancer Res, vol.53, pp.1719-1723, 1993.

D. B. Zimonjic, C. L. Keck, S. S. Thorgeirsson, and N. C. Popescu, Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization, Hepatol Baltim Md, vol.29, pp.1208-1214, 1999.

,

C. Schlaeger, T. Longerich, and C. Schiller, Etiology-dependent molecular mechanisms in human hepatocarcinogenesis, Hepatol Baltim Md, vol.47, pp.511-520, 2008.

R. M. Zubaidah, G. S. Tan, and S. Tan, 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis, Proteomics, vol.8, pp.5086-5096, 2008.

,

H. Wen, H. Ma, and P. Li, Expression of far upstream element-binding protein 1 correlates with c-Myc expression in sacral chordomas and is associated with tumor progression and poor prognosis, Biochem Biophys Res Commun, vol.491, pp.1047-1054, 2017.

X. Xiong, J. Zhang, and W. Liang, Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells, Int J Oncol, vol.49, pp.623-628, 2016.

I. Bièche, S. Lachkar, and V. Becette, Overexpression of the stathmin gene in a subset of human breast cancer, Br J Cancer, vol.78, pp.701-709, 1998.

B. Müller, M. Bovet, and Y. Yin, Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells, J Pathol, vol.237, pp.390-401, 2015.

A. G. Brisbin, Y. W. Asmann, and H. Song, Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development, BMC Med Genet, vol.12, p.156, 2011.

M. C. Boelens, K. Kok, and P. Van-der-vlies, Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis, Lung Cancer Amst Neth, vol.66, pp.372-378, 2009.

P. Moinzadeh, K. Breuhahn, H. Stützer, and P. Schirmacher, Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological graderesults of an explorative CGH meta-analysis, Br J Cancer, vol.92, pp.935-941, 2005.

K. Matsushita, T. Tomonaga, and T. Kajiwara, ) c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy, Front Biosci Landmark Ed, vol.14, pp.3401-3408, 2009.

I. Saito, T. Miyamura, and A. Ohbayashi, Hepatitis C virus infection is associated with the development of hepatocellular carcinoma, Proc Natl Acad Sci, vol.87, pp.6547-6549, 1990.

S. T. Shi and M. M. Lai, Hepatitis C viral RNA: challenges and promises, Cell Mol Life Sci CMLS, vol.58, pp.1276-1295, 2001.

J. Wesely, M. Steiner, and F. Schn?tgen, Delayed Mesoderm and Erythroid Differentiation of Murine Embryonic Stem Cells in the Absence of the Transcriptional Regulator FUBP1, Stem Cells Int, vol.2017, pp.1-12, 2017.

A. Wilson, M. J. Murphy, and T. Oskarsson, ) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation, Genes Dev, vol.18, pp.2747-2763, 2004.

L. Reavie, G. D. Gatta, and K. Crusio, Hematopoietic Stem Cell Differentiation Regulated by a Single Ubiquitin Ligase: Substrate Complex, Nat Immunol, vol.11, pp.207-215, 2010.

B. Hoffman, A. Amanullah, M. Shafarenko, and D. A. Liebermann, The proto-oncogene c-myc in hematopoietic development and leukemogenesis, Oncogene, vol.21, pp.3414-3421, 2002.

S. O. Freytag, Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1, Mol Cell Biol, vol.8, pp.1614-1624, 1988.

B. Hoffman, D. A. Liebermann, M. Selvakumaran, and H. Q. Nguyen, Role of c-myc in myeloid differentiation, growth arrest and apoptosis, Curr Top Microbiol Immunol, vol.211, pp.17-27, 1996.

K. Eppert, K. Takenaka, and E. R. Lechman, Stem cell gene expression programs influence clinical outcome in human leukemia, Nat Med, vol.17, pp.1086-1093, 2011.

M. D. Delgado and J. León, Myc Roles in Hematopoiesis and Leukemia, Genes Cancer, 2010.

J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa, Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit, STEM CELLS, vol.23, pp.16-43, 2005.

R. R. Weidemann, R. Behrendt, and K. B. Schoedel, Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice, Exp Hematol, vol.45, pp.45-55, 2017.

D. A. Landau, E. Tausch, and A. N. Taylor-weiner, Mutations driving CLL and their evolution in progression and relapse, Nature, vol.526, pp.525-530, 2015.

,

C. M. Lindqvist, A. Lundmark, and J. Nordlund, Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes, Oncotarget Sep, vol.27, pp.64071-64088, 2016.

P. Klener, E. Fronkova, and A. Berkova, Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years: Mantle cell lymphoma-variant Richter syndrome, Int J Cancer, vol.139, pp.2252-2260, 2016.

,

J. R. Huth, L. Yu, and I. Collins, NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter, J Med Chem, vol.47, pp.4851-4857, 2004.

S. Au, C. Wong, and J. Lee, EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers, PloS One, vol.8, 2013.

Y. Lv, Y. Meng, and G. , Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma, Sci Rep, vol.5, 2015.

K. M. Niforou, A. K. Anagnostopoulos, and K. Vougas, The proteome profile of the human osteosarcoma U2OS cell line, Cancer Genomics Proteomics, vol.5, pp.63-78, 2008.

S. Varambally, S. M. Dhanasekaran, and M. Zhou, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, vol.419, pp.624-629, 2002.

C. G. Kleer, Q. Cao, and S. Varambally, EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells, Proc Natl Acad Sci U S A, vol.100, pp.11606-11611, 2003.

K. Hosseini, S. Kolterer, S. Steiner, and M. , Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE, Biochem Pharmacol, vol.146, pp.53-62, 2017.

X. Zhou, M. N. Edmonson, and M. R. Wilkinson, Exploring genomic alteration in pediatric cancer using ProteinPaint, Nat Genet, vol.48, pp.4-6, 2016.
DOI : 10.1038/ng.3466
URL : http://europepmc.org/articles/pmc4892362?pdf=render

J. Barretina, G. Caponigro, and N. Stransky, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.483, pp.603-607, 2012.

A. Idbaih, F. Ducray, and C. Dehais, SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas, PloS One, vol.7, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00911465

D. P. Cahill, D. N. Louis, J. Cairncross, T. Idh, and F. , Molecular background of oligodendroglioma: 1p/19q, vol.4, pp.287-294, 2015.
DOI : 10.2217/cns.15.32

L. Erdem-eraslan, D. Heijsman, and M. De-wit, Tumor-specific mutations in low-frequency genes affect their functional properties, J Neurooncol, vol.122, pp.461-470, 2015.
DOI : 10.1007/s11060-015-1741-1
URL : https://link.springer.com/content/pdf/10.1007%2Fs11060-015-1741-1.pdf

L. Zhang, Y. Liu, and M. Wang, EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients, J Mol Cell Biol, 2017.
DOI : 10.1093/jmcb/mjx056

J. Ma, M. Chen, and S. Xia, Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression, Int J Oncol, vol.42, pp.1093-1104, 2013.

J. Samarin, V. Laketa, and M. Malz, PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells, Hepatology, vol.63, pp.813-826, 2016.

F. Zhang, Q. Tian, and Y. Wang, Far upstream element-binding protein 1 (FUBP1) is overexpressed in human gastric cancer tissue compared to non-cancerous tissue, Onkologie, vol.36, pp.650-655, 2013.
DOI : 10.1159/000355659

M. Y. Jia and Y. J. Wang, Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue, Neoplasma, vol.61, pp.533-540, 2014.

J. Gagné, P. Gagné, and J. M. Hunter, Proteome profiling of human epithelial ovarian cancer cell line TOV-112D, Mol Cell Biochem, vol.275, pp.25-55, 2005.

Q. Zhong, Z. Liu, and Z. Lin, The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma. Clin Cancer Res clincanres.0352, 2016.
DOI : 10.1158/1078-0432.ccr-17-0352
URL : http://clincancerres.aacrjournals.org/content/24/3/659.full.pdf